Distribution of lymphoid nodules, aberrant crypt foci and tumours in the colon of carcinogen-treated rats

British Journal of Cancer

Volumn 73, Issue 7, 1996, Pages 893-898

  Cameron, I L ^a   Garza, J ^a   Hardman, W E ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

Aberrant crypt foci; Colon carcinogenesis; Dimethylhydrazine; Lymphoid nodules; Rat

Indexed keywords

1,2 DIMETHYLHYDRAZINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COLON ADENOCARCINOMA; COLON CANCER; COLON CARCINOGENESIS; INTESTINE CRYPT; LYMPH NODE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030010353     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.159     Document Type: Article

References (29)

1. AMERICAN INSTITUTE OF NUTRITION. (1977). Report of the American Institute of Nutrition ad hoc committee on standards for nutritional studies. J. Nutr., 107, 1340-1348.
2. BLAND PW AND BRITTON DC. (1984). Morphological study of antigen-sampling structures in the rat large intestine. Infect. Immun., 43, 693-699.
3. CADERNI G, GIANNINI A, LANCIONI L, LUCERI C, BIGGERI A AND DOLARA P. (1995). Characterisation of aberrant crypt foci in carcinogen-treated rats: association with intestinal carcinogenesis. Br. J. Cancer, 71, 763-769.
4. CARTER JW, LANCASTER HK, HARDMAN WE AND CAMERON IL. (1994). Distribution of intestine-associated lymphoid-tissue, aberrant crypt foci and tumours in the large bowel of 1,2-dimethylhydrazine-treated mice. Cancer Res., 54, 4304-4307.
5. DESCHNER EE, LYTLE JS, WONG G, RUPERTO JF AND NEWMARK HL. (1990). The effect of dietary omega-3 fatty acids (fish oil) on azoxymethanol-induced focal areas of dysplasia and colon tumour incidence. Cancer, 66, 2350-2356.
6. HARDMAN WE AND CAMERON IL. (1994). Colonic crypts located over lymphoid nodules of 1,2-dimethylhydrazine-treated rats are hyperplastic and at high risk of forming adenocarcinomas. Carcinogenesis, 15, 2353-2361.
7. HARDMAN WE, CAMERON IL, HEITMAN DW AND CONTRERAS E. (1991). Demonstation of the need for end point validation of putative biomarkers: failure of aberrant crypt foci to predict colon cancer incidence. Cancer Res., 51, 6388-6392.
8. JEN J, POWELL SM, PAPADOPOULOS N, SMITH KJ, HAMILTON SR, VOGELSTEIN B AND KINZLER KW. (1994). Molecular determinants of dysplasia in colorectal lesions. Cancer Res., 54, 5523-5526.
9. LAM LKT AND ZHANG J. (1991). Reduction of aberrant crypt formation in the colon of CF1 mice by potential chemopreventive agents. Carcinogenesis, 12, 2311-2315.
10. McLELLAN EA AND BIRD RP. (1988). Aberrant crypts: potential preneoplastic lesions in the murine colon. Cancer Res., 48, 6187-6192.
11. MAGNUSON BA AND BIRD RP. (1993). Reduction of aberrant crypt foci induced in rat colon with azoxymethane or methylnitro-sourea by feeding cholic acid. Cancer Lett., 68, 15-23.
12. MAGNUSON BA, CARR I AND BIRD RP. (1993). Ability of aberrant crypt foci characteristics to predict colonic tumour incidence in rats fed cholic acid. Cancer Res., 53, 4499-4504.
13. MARTIN MS, HAMMAN A AND MARTIN F. (1986). Gut-associated lymphoid tissues and 1,2-dimethylhydrazine intestinal tumours in the rat: an histological and immunoenzymatic study. Int. J. Cancer, 38, 75-80.
14. NAUSS KM, LOCNISKAR M AND NEWBERNE PM (1984). Morphology and distribution of 1,2-dimethylhydrazine dihydrochloride-induced colon tumours and their relationship to gut-associated lymphoid tissue in rats. J. Natl. Cancer Inst., 73, 915-921.
15. α users' Guide, McGraw-Hill: New York.
16. O'RIORDAN MA, PRETLOW TG, STELLATO TA AN PRETLOW TP. (1991). Effect of selenium on the induction of aberrant crypts in the colons of rats treated with azoxymethane. Proc. Am. Assoc. Cancer Res., 32, 147.
17. PERIERA MA AND KHOURY MD. (1991). Prevention by chemopreventive agents of azoxymethane-induced foci of aberrant crypts in rat colon. Cancer Lett., 61, 27-33.
18. PEREIRA MA, BARNES LH, RASSMAN VL, KELLOFF GV AND STEELE VE. (1994). Use of azoxymethane-induced foci of aberrant crypts in rat colon to identify potential cancer chemopreventive agents. Carcinogenesis, 15, 1049-1054.
19. PRETLOW TP. (1995). Aberrant crypt foci and K-ras mutations: earliest recognised players or innocent bystanders in colon carcinogenesis. Gastroenterology, 108, 600-609.
20. RAO CV, DESAI D, SIMI B, KULKARNI N, AMIN S AND REDDY BS (1993). Inhibitory effect of caffeic acid esters on modulation of azoxymethane-induced early events and aberrant crypt foci formation in rat colon. Proc. Am. Assoc. Cancer Res., 34, 165(Abstract).
21. SHAMSUDDIN AM AND HOGAN ML. (1984). Large intestinal carcinogenesis. II. Histogenesis and unusual features of low-dose azoxymethane-induced carcinomas in F344 rats. J. Natl. Cancer Inst., 73, 1297-1305.
22. SHIMAMOTO F AND VOLLMER E. (1987). Changes in intestinal mucosa above lymph follicles during carcinogenesis in rats. J. Cancer Res. Clin. Oncol., 113, 41-50.
23. SMITH AJ, STERN HS, PENNER M, HAY K, MITRI A, BAPAT BV AND BALLINGER S. (1994). Somatic APC and K-ras codon 12 mutations in aberrant crypt foci from human colons. Cancer Res., 54, 5527-5530.
24. THORUP I, MEYER O AND KRISTIANSEN E (1994). Influence of a dietary fiber on development of dimethylhydrazine-induced aberrant crypt foci and colon tumour incidence in wistar rats. Nutr. Cancer, 21, 177-192.
25. TUDEK B, BIRD RP AND BRUCE WR. (1989). Foci of aberrant crypts in the colons of mice and rats exposed to carcinogens associated with foods. Cancer Res., 49, 1236-1240.
26. WARGOVICH MJ, HARRIS C, CHEN C, PALMER C, STEELE VE AND KELLOFF GJ. (1992). Growth kinetics and chemoprevention of aberrant crypts in the rat colon. J. Cell. Biochem., 16G, 51-54.
27. WILLIAMS GM AND WATANBE K. (1978). Quantitative kinetics of development of n-2-fluorenylacetamide induced, altered (hyperplastic) hepatocellular foci resistant to iron accumulation and of their reversion or persistence following removal of carcinogen. J. Natl. Cancer. Inst., 61, 113-121.
28. YAMASHITA N, MINAMOTO T, OCHIAI A, ONDA M AND ESUMI H. (1995). Frequent and characteristic K-ras activation and absence of p53 protein accumulation in aberrant crypt foci of the colon. Gastroenterology, 108, 434-440.
29. ZHANG XM, STAMP D, MINKIN S, MEDLINE A, CORPET DE, BRUCE WR AND ARCHER MC. (1992). Promotion of aberrant crypt foci and cancer in rat colon by thermolysed protein. J. Natl. Cancer Inst., 84, 1026-1030.